Director Clinicial Lung Cancer Program, Associate Professor of Clinical Medicine
Medical Oncology
University of Texas Medical School
University of South Florida Hospitals
In 2008, Garland was named as the principal investigator for a clinical trial of trimodal therapy as an intervention for mesothelioma patients and patients with other solid tumors.
Bio
Linda Garland, M.D., knows all about the steep challenge that mesothelioma still presents to medical providers, but she also sees the opportunities it brings.
Garland, director of the clinical lung cancer program and associate professor of clinical medicine at Arizona Cancer Center, hailed the advances in genetic tumor profiling that she has seen recently, prompting an article she coauthored entitled "Individualizing Mesothelioma Treatment: Small Steps Into a Brighter Future." The article calls for increasingly personalized treatment for patients.
"The availability of pleural tumor from diagnostic biopsies and pleurectomy specimens provides a distinct opportunity for molecular/genetic studies that can yield prognostic and predictive biomarkers upon which individualized therapy can be designed," she wrote.
Garland, whose specialty is medical oncology, has research interests in malignant chest diseases and the use of experimental therapeutics. The diseases of particular interest to her include lung cancer, mesothelioma and other rare mediastinal tumors. She has a special interest in designing "finely-tuned," therapy.
Her clinical focus has been on mesothelioma, small-cell lung cancer, non-small cell lung cancer, head and neck cancer and thyroid cancer.
Do You Have Questions About Mesothelioma?
To help patients understand mesothelioma cancer and related diseases, The Mesothelioma Center provides a free packet that contains information specific to each diagnosis as well as a list of top doctors and cancer centers. The packet also discusses the financial assistance options that could help cover medical costs. Click here to learn more about the care packet and how to get your complimentary copy.
-
05/24/2012 -
One of the biggest asbestos-abatement jobs ever done in Buffalo, New York, is being handled now by a local company with a history of asbestos-related ..
-
05/23/2012 -
A new class of anti-cancer drugs is nearing the clinical trial phase and may eventually be available for treatment of aggressive diseases like pancrea ..
-
05/23/2012 -
School districts all across America have been wrestling in recent years with the task of removing and disposing of toxic asbestos from older buildings ..
© 2012 The Mesothelioma Center |
Last Modified Thursday, February 9th, 2012 | Disclaimer | Privacy Policy |
The information provided by The Mesothelioma Center is not a substitute for professional medical advice, diagnosis or treatment.
Sponsored by a law firm concentrating in asbestos litigation, The Peterson Firm, LLP with offices at 1350 Connecticut Ave, NW, Fifth Floor, Washington DC 20036.
